Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM-CHOC-PEN in AYA with CNS Malignancies
NCT03668847Phase 2Completed
- Sponsor
- DEKK-TEC, Inc.
- Start
- Jan 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mipicoledine in cancer, brain metastases, sponsored by DEKK-TEC, Inc.. Started Jan 2019; status: completed.
02
Drugs
mipicoledine
03
Conditions
cancerbrain metastases
Beyond the preview
Go deeper on NCT03668847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668847.